Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Working Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.101.421.241.251.15

What is the latest Working Capital/Sales ratio of NATCO PHARMA ?

The latest Working Capital/Sales ratio of NATCO PHARMA is 1.10 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.10
Mar20241.42
Mar20231.24
Mar20221.25
Mar20211.15

How is Working Capital/Sales of NATCO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.1
-22.54
Mar2024 1.42
14.52
Mar2023 1.24
-0.80
Mar2022 1.25
8.70
Mar2021 1.15 -

Other Financial Ratios of NATCO PHARMA


Compare Working Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹16,410.0 Cr 0.2% 9.9% -34.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 1.3% 2.7% 10% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

0.2%

9.9%

-34.7%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses